← Back to all trials
Completed
NCT05625308
Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions
Conditions: Papilloma, Cervix Lesion
Sex: Female
Ages: 18 Years – 55 Years
Phase: NA
Enrollment: 40
Sponsor: Lo.Li.Pharma s.r.l
Location: Italy
Summary
To test the efficacy of a newly-commercialized formula, 40 HPV-positive women displaying chronic cervicitis, mild dysplasia or moderate dysplasia.
Women in the study group took one tablet per day containing 200 mg of EGCG, 400 mcg of Folic Acid, 1 mg of Vitamin B12 and 50 mg of Hyaluronic Acid for twelve weeks.
Women in the control group received no treatment.
Eligibility Criteria
Inclusion Criteria:HPV infectionsOccurrence of low-grade cervical lesionsExclusion Criteria:Diagnosis of malignancy or severe cervical lesionsConcurrent uterine pathologiesPregnancy or intended to seek pregnancy in the next three monthsCancer
Source: ClinicalTrials.gov (NCT05625308). StuddyBuddy aggregates publicly available trial information.
